Submitted by Anonymous (not verified) on 21 November 2025 - 8:45
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Date of authorisation: 17/11/2025, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Usgena, ustekinumab, Date of authorisation: 17/11/2025, Status: Authorised